Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
 

**Pharmacist** Washington Metropolitan Society of Health-System Pharmacists Presents The Fall 2018 Meeting: Emerging Frontiers II


Date: Sep 22, 2018 07:00 AM - 05:00 PM

Fee

$0.00

CE Hours

6.00

CE Units

0.600

Registration closes on Nov 17, 2018 10:30 PM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists
  • Pharmacy Technicians

Accreditation(s)

Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Joint Provider(s)

Washington Metropolitan Society of Health-System Pharmacists(WMSHP); University of Maryland School of Pharmacy

 

 

Registration closes on Nov 17, 2018 at 10:30 PM

Registration Closed  

Objectives

  • Define gender identity in the LGBTQ Community
  • Review statistics regarding HIV amongst transgender people
  • List hormonal therapies used by transgender people
  • Recognize possible drug interactions between anti-retrovirals and hormonal therapies
  • Identify barriers to healthcare in the LGBTQ community
  • Identify the role of pharmacists in bridging relevant healthcare gaps in the LGBTQ community

Speaker(s)/Author(s)

Alsean Bryant, PharmD, AAHIVP
Clinical Pharmacist

Activity Number

0010-9999-18-019-L01-P
Date: 09/22/18
Time: 08:00 AM - 09:00 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • At the conclusion of this program, the participant should be able to: 1. Explain the use of common genetic markers to predict treatment response in Type 2 Diabetes
  • 2. Explain how diagnosis of specific and highly penetrant forms of diabetes informs the selection of appropriate treatment
  • 3. Describe pharmacogenetic approaches used to identify novel drug target treatments for Type 2 Diabetes

Speaker(s)/Author(s)

Toni Pollin, PhD, PhD
Associate Professor, University of Maryland,, School of Medicine

Activity Number

0010-9999-18-018-L01-P
Date: 09/22/18
Time: 09:00 AM - 10:00 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • 1. Identify previous and current guidelines for HIV treatment
  • 2. Describe clinical uses of recently marketed anti-retrovirals
  • 3. Describe the potential influence new anti-retrovirals will have on HIV management

Speaker(s)/Author(s)

Neha Sheth Pandit, Pharm.D., AAHIVP, BCPS
University of Maryland, College of Pharmacy

Activity Number

0010-9999-18-020-L02-P
Date: 09/22/18
Time: 10:00 AM - 11:00 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • 1. Define Pharmacy Informatics
  • 2. Identify the role of pharmacy informatics
  • 3. Describe the challenges of Computerized Prescriber Order Entry (CPOE)
  • 4. Describe the concept of "Systemness" as applied to Healthcare Systems
  • 5. Define the limitation of Information Technology (IT)
  • 6. Describe the future of Pharmacy Informatics and healthcare delivery

Speaker(s)/Author(s)

Justin Sebakijje, PharmD, BCPS
MedStar Washington Hospital Center

Activity Number

0010-9999-18-015-L04-P
Date: 09/22/18
Time: 01:30 PM - 02:30 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • 1. Define Medication Error
  • 2. Describe the impact of medication errors on the healthcare system
  • 3. List common causes of medication errors
  • 4. Identify ways to prevent medication errors

Speaker(s)/Author(s)

Youness Karodeh, PharmD, RPh
Associate Professor, Howard University College of Pharmacy

Activity Number

0010-9999-18-016-L05-P
Date: 09/22/18
Time: 02:30 PM - 03:30 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • 1) Describe the Division of Medication Error Prevention and Analysis’ role in pre-marketing and post-marketing activities to prevent and address medication errors.
  • 2) Recognize current strategies aimed to increase the safe use of drug products by minimizing use error as relates to design, naming, labeling, and/or packaging of drug products.
  • 3) State examples of regulatory action(s) taken to address recent medication errors.
  • 4) Explain the role of pharmacists in the prevention, mitigation and identification of medication errors.

Speaker(s)/Author(s)

Lolita White, PharmD
FDA

Activity Number

0010-9999-18-017-L07-P
Date: 09/22/18
Time: 03:45 PM - 04:45 PM

CE Hours

1.00
Registration Closed